Integrated Biopharma, Inc.
INBP
$0.3069
$0.01194.03%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.37% | 6.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.37% | 6.83% | |||
| Cost of Revenue | -6.56% | 6.84% | |||
| Gross Profit | -14.59% | 6.78% | |||
| SG&A Expenses | 9.99% | -0.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.45% | 6.34% | |||
| Operating Income | -58.78% | 21.89% | |||
| Income Before Tax | -63.29% | 21.74% | |||
| Income Tax Expenses | -71.84% | 67.81% | |||
| Earnings from Continuing Operations | -55.21% | -3.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -55.21% | -3.36% | |||
| EBIT | -58.78% | 21.89% | |||
| EBITDA | -50.69% | 18.20% | |||
| EPS Basic | -55.81% | -3.37% | |||
| Normalized Basic EPS | -58.10% | 22.09% | |||
| EPS Diluted | -56.98% | -3.37% | |||
| Normalized Diluted EPS | -58.25% | 22.62% | |||
| Average Basic Shares Outstanding | 0.25% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.13% | -0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
